The reported impact of non-communicable disease investment cases in 13 countries.

Non-communicable diseases (NCDs) are a leading health and development challenge worldwide. Since 2015, WHO and the United Nations Development Programme have provided support to governments to develop national NCD investment cases to describe the socioeconomic dimensions of NCDs. To assess the impact of the investment cases, semistructured interviews and a structured process for gathering written feedback were conducted between July and October 2022 with key informants in 13 countries who had developed a national NCD investment case between 2015 and 2020. Investment cases describe: (1) the social and economic costs of NCDs, including their distribution and projections over time; (2) priority areas for scaled up action; (3) the cost and returns from investing in WHO-recommended measures to prevent and manage NCDs; and (4) the political dimensions of NCD responses. While no country had implemented all the recommendations set out in their investment case reports, actions and policy changes attributable to the investment cases were identified, across (1) governance; (2) financing; and (3) health service access and delivery. The pathways of these changes included: (1) stronger collaboration across government ministries and partners; (2) advocacy for NCD prevention and control; (3) grounding efforts in nationally owned data and evidence; (4) developing mutually embraced 'language' across health and finance; and (5) elevating the priority accorded to NCDs, by framing action as an investment rather than a cost. The assessment also identified barriers to progress on the investment case implementation, including the influence of some private sector entities on sectors other than health, the impact of the COVID-19 pandemic, and changes in senior political and technical government officials. The results suggest that national NCD investment cases can significantly contribute to catalysing the prevention and control of NCDs through strengthening governance, financing, and health service access and delivery.

Innovations to Sustain Non-Communicable Disease Services in the Context of COVID-19: Report from Pakkred District, Nonthaburi Province, Thailand.

During the COVI9-19 pandemic, Pakkred hospital in Thailand implemented innovative practices to ensure the continuation of essential medical services for non-communicable disease patients. These practices included decentralized care, telemedicine, home blood pressure monitoring, community delivery of medicines, and facility infrastructure changes. Despite the decrease in hospital visits by hypertension patients during the pandemic, our results suggest that this package of interventions may have contributed to sustained hypertension and diabetes control rates in Pakkred district.

Estimated dietary sodium intake in Thailand: A nationwide population survey with 24-hour urine collections.

Thailand has committed to reducing population sodium intake by 30% by 2025. However, reliable nationally representative data are unavailable for monitoring progress toward the goal. We estimated dietary sodium consumption using 24-hour urinary analyses in a nationally representative, cross-sectional population-based survey. We selected 2388 adults (aged ≥ 18 years) from the North, South, North-east, Central Regions, and Bangkok, using multi-stage cluster sampling. Mean sodium excretion was inflated by 10% to adjust for non-urinary sources. Multivariate logistic regression was performed to assess factors associated with sodium consumption ≥ 2000 mg. Among 1599 (67%) who completed urine collection, mean age was 43 years, 53% were female, and 30% had hypertension. Mean dietary sodium intake (mg/day) was 3636 (±1722), highest in South (4108 ± 1677), and lowest in North-east (3316 ± 1608). Higher sodium consumption was independently associated with younger age (Adjusted Odds Ratio (AOR) 2.81; 95% Confidence interval (CI): 1.53-5.17; p = .001); higher education (AOR 1.79; 95% CI: 1.19-2.67; p = .005), BMI ≥ 25 (AOR 1.55; 95% CI: 1.09-2.21; p=.016), and hypertension (AOR 1.58; 95% CI: 1.02-2.44; p = .038). Urine potassium excretion was 1221 mg/day with little variation across Regions. Estimated dietary sodium consumption in Thai adults is nearly twice as high as recommended levels. These data provide a benchmark for future monitoring.

Batch and continuous packed column studies of cadmium biosorption by Hydrilla verticillata biomass.

The removal of heavy metal ions by the nonliving biomass of aquatic macrophytes was studied. We investigated Cd biosorption by dry Hydrilla verticillata biomass. Data obtained in batch experiments indicate that H. verticillata is an excellent biosorbent for Cd. Cd was rapidly adsorbed and such adsorption reached equilibrium within 20 min. The initial pH of the solution affected Cd sorption efficiency. Results obtained from the other batch experiments conformed well to those obtained using the Langmuir model. The maximum adsorption capacity q(max) for H. verticillata was 15.0 mg/g for Cd. The breakthrough curve from the continuous flow studies shows that H. verticillata in the fixed-bed column is capable of decreasing Cd concentration from 10 to a value below the detection limit of 0.02 mg/l. The presence of Zn ions affected Cd biosorption. It can be concluded that H. verticillata is a good biosorbent for treating wastewater with a low concentration of Cd contaminants.